Latest News
FTSE 250 movers: Oil surge lifts mid-caps, N Brown down
Led by a group of resources stocks and a late surge in oil prices, the FTSE 250 moved into positive territory on Monday afternoon.
PuriCore completes disposal of supermarket retail business
Emerging specialty biopharmaceutical company PuriCore announced on Monday that the disposal of its supermarket retail business, as first indicated on 20 September, had completed.
Director dealings: Dunelm CEO and wife go on share shopping trip
After shares in the homewares retailer sank below their post-referendum low, Dunelm chief executive John Browett and his wife popped out on a bargain-hunting trip and returned home with a bagful of shares.
Twitter slides on reported lack of interest in its sale
Social media company Twitter fell more than 13% in Monday's premarket trading as it emerged at the weekend that high-profile parties were not interested in tabling bids.
Parliament will have a role in Brexit talks, Downing Street says
Parliament will have a role in shaping the country’s Brexit strategy, but a second vote by MPs on Britons’ decision to leave was out of the question, Downing Street said.
Tuesday preview: Ted Baker to report first half profit growth despite Brexit
Ted Baker is expected to report on Tuesday an increase in first half pre-tax profits as the luxury fashion brand continues to grow on an international level.
Waterman full-year profit rises, dividend lifted
Engineering and environmental consultancy Waterman reported a jump in full-year profit as revenue grew and the company lifted its dividend.
Citi reiterates sell on Lloyds, cuts target
The Financial Conduct Authority's consultation paper 16/20 released in August would see Lloyds book further charges linked to payment protection insurance mis-selling, analysts at Citi said.
Allergy Therapeutics examines potential of adjuvant portfolio
Allergy Therapeutics will look into potential wider applications for its adjuvant technology after recent clinical research produced encouraging indications about both allergy vaccination and infectious disease applications.
Thalassa acquires Papua shares while subsidiary sells more data
Thalassa announced on Monday that WGP Survey, a wholly owned subsidiary of Thalassa’s own subsidiary WGP Group, has made further sales of the multi client data acquired with TGS-NOPEC Geophysical Company ASA in 2014.
Russia ready to join oil production freeze, Putin says
Crude oil futures moved higher after Russian president Vladimir Putin signalled from Istanbul that his country was willing to join a freeze on production.
Results round-up
Data and analytics company YouGov’s full year revenues rose, but cautioned against Brexit uncertainty as it aims to continue expanding internationally.
Ixico to receive €1m from EU Alzheimer's project
AIM-listed pharmaceutical Ixico is to receive €1m as a partner in an EU public-private consortium, which has the potential for long-term revenue through the development of diagnostic and disease management technologies for Alzheimer's.
Polls show victory for Clinton in debate as grip tightens
Hillary Clinton appears to have triumphed in the polls on Sunday night's televised debate with Republican rival Donald Trump, and consolidated her lead in the national surveys.
Monday broker round-up
Easyjet: Societe Generale downgrades to sell with a target price of 820p.
Fed's Fischer sees little risk of falling behind the curve
Fed watchers continued to try to infer the pace and timing of the next interest rate increases over the weekend, after the central bank's vice-President, Stanley Fischer described the decision to stay put in September as "a close call".
Mylan surges after EpiPen settlement
Mylan shares surged in pre-market trade after the company said at the end of last week that it had agreed the terms of a $465m settlement with the US Department of Justice and other government agencies over how it charged Medicaid for its allergy shot pen EpiPen.
Samsung halting Galaxy Note 7 production after more battery issues
South Korean electronics giant Samsung is facing another headache with its Galaxy Note 7 smartphone, as it halts production of the device following more issues with overheating batteries.
Apple and Samsung set for Supreme Court battle in US
Tech rivals Apple and Samsung will face off in a $399m patent case in the US Supreme Court on Tuesday in what will be a landmark case for smartphone makers.
SVG Capital rallies as HarbourVest ups offer
Shares in SVG Capital rose on Monday after US rival HarbourVest Bidco proposed to buy its investment portfolio for at least £783. 1m, trumping the current offer from Goldman Sachs and the Canada Pension Plan Investment Board.